Attilio Orazi

Author PubWeight™ 5.11^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.	Mod Pathol	2015	0.92
2	Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.	Oncotarget	2015	0.88
3	Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.	Oncotarget	2015	0.84
4	Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.	Mod Pathol	2015	0.82
5	Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.	Oncotarget	2015	0.82
6	Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.	Mod Pathol	2015	0.81